dipyridamole has been researched along with Bipolar Disorder in 6 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Bipolar Disorder: A major affective disorder marked by severe mood swings (manic or major depressive episodes) and a tendency to remission and recurrence.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Dihydropyridines and diltiazem were associated with a decreased risk of psychiatric hospitalization in bipolar disorder." | 8.12 | Allopurinol, dipyridamole and calcium channel blockers in the treatment of bipolar disorder - A nationwide cohort study. ( Lähteenvuo, M; Lintunen, J; Taipale, H; Tanskanen, A; Tiihonen, J, 2022) |
| "Dihydropyridines and diltiazem were associated with a decreased risk of psychiatric hospitalization in bipolar disorder." | 4.12 | Allopurinol, dipyridamole and calcium channel blockers in the treatment of bipolar disorder - A nationwide cohort study. ( Lähteenvuo, M; Lintunen, J; Taipale, H; Tanskanen, A; Tiihonen, J, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Lintunen, J | 1 |
| Lähteenvuo, M | 1 |
| Tanskanen, A | 1 |
| Tiihonen, J | 1 |
| Taipale, H | 1 |
| Nosengo, N | 1 |
| Machado-Vieira, R | 1 |
| Soares, JC | 1 |
| Lara, DR | 1 |
| Luckenbaugh, DA | 1 |
| Busnello, JV | 1 |
| Marca, G | 1 |
| Cunha, A | 1 |
| Souza, DO | 1 |
| Zarate, CA | 1 |
| Kapczinski, F | 1 |
| BARCIASALORIO, D | 1 |
| BORREGUERO, AD | 1 |
| Lereboullet, J | 1 |
| Rosa, A | 1 |
| Olivier-Martin, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Double-blind, Randomized, Placebo-controlled 4-week Study on the Efficacy and Safety of the Purinergic Agents Allopurinol and Dipyridamole in Acute Bipolar Mania.[NCT00560079] | Phase 4 | 180 participants (Actual) | Interventional | 2003-11-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for dipyridamole and Bipolar Disorder
| Article | Year |
|---|---|
A double-blind, randomized, placebo-controlled 4-week study on the efficacy and safety of the purinergic agents allopurinol and dipyridamole adjunctive to lithium in acute bipolar mania.
Topics: Acute Disease; Adolescent; Adult; Aged; Allopurinol; Antipsychotic Agents; Bipolar Disorder; Diagnos | 2008 |
5 other studies available for dipyridamole and Bipolar Disorder
| Article | Year |
|---|---|
Allopurinol, dipyridamole and calcium channel blockers in the treatment of bipolar disorder - A nationwide cohort study.
Topics: Adenosine; Allopurinol; Bipolar Disorder; Calcium Channel Blockers; Cohort Studies; Dihydropyridines | 2022 |
Can you teach old drugs new tricks?
Topics: Animals; Azoles; Bipolar Disorder; Carbazoles; Clinical Trials, Phase II as Topic; Dipyridamole; Dru | 2016 |
[STUDY OF CEREBRAL HEMODYNAMICS IN THE DEPRESSIVE STATES].
Topics: Amitriptyline; Bipolar Disorder; Cerebrovascular Circulation; Depression; Depressive Disorder; Depre | 1963 |
[TREATMENT OF DEPRESSION WITH PERSANTIN].
Topics: Bipolar Disorder; Convulsive Therapy; Depression; Depressive Disorder; Dipyridamole; Electroconvulsi | 1964 |
[Neuropsychiatry in 1973].
Topics: Aspirin; Bipolar Disorder; Dipyridamole; Heart Diseases; Humans; Hydrocephalus; Hypoxia, Brain; Isch | 1973 |